ACLXMID

Arcellx, Inc.

HealthcareBiotechnology
$115.07
$0.00(+0.00%)
52W$47.86
$115.13
Updated May 6, 12:00 AM
RSI80
RS Rating85/99
Beta-0.34
Volatility88%
F-Score1/9
Mkt Cap$6.7B
STAGE 2 UPTREND

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

STAGE 2 UPTREND

Arcellx, Inc. is in a confirmed Stage 2 uptrend, with price holding above all major moving averages and trend structure remaining intact. Relative strength is leading (RS Rating: 85), indicating clear outperformance against the broad market. Earnings contraction of 14% provides fundamental context to the price action. However, with RSI at 80, the stock is extended and may be prone to a short-term pullback.

Relative Strength
85
out of 99
Market Leader
Trend Score
4/4
Minervini Criteria
STAGE 2 UPTREND
Risk (Beta)
-0.34
vs S&P 500
LOW VOL
52W Position
100%
from 52W low
Near High
Trend & Momentum Analysis

Trend Template (Minervini)

STAGE 2 UPTREND4/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$111.71
50 SMA > 100 SMA$89.66
100 SMA > 150 SMA$87.91
150 SMA > 200 SMA$83.94

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$114.93+0.12%ABOVE
50 SMA$111.71+3.01%ABOVE
100 SMA$89.66+28.34%ABOVE
150 SMA$87.91+30.90%ABOVE
200 SMA$83.94+37.08%ABOVE

Price Performance

1D+0.0%
1W+0.0%
1M+0.3%
3M+71.9%
6M+31.5%
YTD+81.7%
1Y+78.0%
3Y+38.2%
52-Week Trading Range100% from low
$115.07
52W Low$47.86
52W High$115.13

Technical Indicators

RSI (14)OVERBOUGHT
79.9
305070
VCP ScoreCOOL
5/10
Base depth: 45.2%

Risk Profile

Beta
-0.34
52W Vol
88%
ATR
$0.11
Max DD (1Y)
-33%

Volume Analysis

Today
50D Avg
1.77M
Vol Ratio
0.00x
Liquidity
LIQUID

Earnings Momentum

Q1'25-707%
$-1.13
Q2'25-84%
$-0.94
Q3'25-106%
$-0.99
Q4'25-14%
$-1.00
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:
5 Years:
3 Years:
TTM:-79.35%

Compounded Profit Growth

10 Years:
5 Years:
3 Years:
TTM:-101.99%

Stock Price CAGR

10 Years:+21.22%
5 Years:+46.94%
3 Years:+38.22%
1 Year:+77.99%

Return on Equity

10Y Avg:-161.5%
5Y Avg:-137.2%
3Y Avg:-32.2%
Last Year:-55.4%

Key Metrics

Market Cap$6.7B
Gross Margin70.0%
Net Margin-10.3%
Piotroski F-Score1/9

Frequently Asked Questions

Is ACLX in an uptrend right now?

ACLX has a trend score of 4/4 based on Minervini's Stage Analysis. Yes, ACLX is in a Stage 2 uptrend with price above all major moving averages (50, 100, 150, 200 SMA) properly stacked.

Is ACLX overbought or oversold?

ACLX's RSI (14) is 80. The stock is in overbought territory (RSI > 70), which may signal a pullback.

Is ACLX outperforming the market?

ACLX has a Relative Strength (RS) Rating of 85 out of 99. Yes, ACLX is a market leader, outperforming 85% of all stocks over the past 12 months.

Where is ACLX in its 52-week range?

ACLX is trading at $115.07, which is 100% of its 52-week high ($115.13) and 100% above its 52-week low ($47.86).

How volatile is ACLX?

ACLX has a Beta of -0.34 and 52-week volatility of 88%. It's less volatile than the S&P 500 - generally more stable.

Disclaimer: Data is for informational purposes only. May be delayed or contain errors. Past performance does not guarantee future results. This is not financial advice. Always conduct your own research and consult professionals before making investment decisions.